|
**Overview**: Prothrombin Time Studies Panel**Introduction**: The Prothrombin Time Studies Panel is a diagnostic tool designed to assess coagulation status using plasma samples. In India, coagulopathy (prolonged PT/INR) is common in liver disease (~10-15 percent of cirrhosis patients), vitamin K deficiency, warfarin therapy, and DIC, with high prevalence of liver disorders (alcohol, hepatitis) in rural/low-SES populations. High morbidity from under-testing leading to delayed vitamin K or FFP in bleeding patients, or inappropriate warfarin dosing causing hemorrhage or thrombosis. Per hematology practices aligned with ICMR and Indian Society of Haematology & Blood Transfusion guidelines, the test employs coagulation assay for PT, INR, APTT, and thrombin time over 1-2 days with high accuracy, valuable for evaluating extrinsic pathway, monitoring anticoagulation, and detecting liver synthetic dysfunction. This diagnostic falls under coagulation screening and targets patients with bleeding, liver disease, or on warfarin, addressing accurate detection to guide vitamin K, FFP, or dose adjustment. With elevated morbidity due to underdiagnosis, the test supports public health efforts by enabling precise coagulation profiling and reducing bleeding/thrombotic complications. Its plasma-based approach ensures reliable functional assessment.**Other Names**: PT Studies Pnl.**FDA Status**: FDA approved, CLIA certified for hematology, compliant with 2025 standards.**Historical Milestone**: PT/INR standard since 1940s; in India, routine in liver/thrombosis clinics.**Purpose**: The test assesses 4 parameters including PT to guide coagulation status assessment, monitor anticoagulation, inform therapy.**Test Parameters**: 1. PT, 2. INR, 3. APTT, 4. Thrombin Time.**Pretest Condition**: No fasting required; patients should report bleeding or liver symptoms.**Specimen**: 3 mL plasma in NaCit tube, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: 8 hours with proper handling to preserve coagulation factors, ensuring reliable test performance.**Sample Stability at Refrigeration**: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on warfarin use, liver disease.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of undetected coagulopathy including hemorrhage, benefits of screening, and minimal discomfort from sampling.**Procedural Considerations**: The test involves sample processing using coagulation assay by trained personnel to ensure sterile technique and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, or heparin contamination can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Prolonged PT/INR indicates extrinsic pathway defect or liver dysfunction, necessitating specialist input.**Specialist Consultation**: Hematologists should be consulted for management.**Additional Supporting Tests**: Mixing studies, factor assays for confirmation.**Test Limitations**: Affected by anticoagulants; comprehensive approach required.**References**: Indian Journal of Hematology 2024, Coagulation Studies India 2023. |
